Table 2 Characteristics of hypertension in the patients with acute aortic disease a
Variables | OI (+) group (n = 67) | OI (−) group (n = 141) | P |
|---|---|---|---|
Hypertension duration | 5.87 ± 6.89 | 5.99 ± 6.75 | 0.909 |
Hypertension grade | 0.437 | ||
Grade 1 | 8.96% (6) | 9.22% (13) | |
Grade 2 | 20.90% (14) | 29.08% (41) | |
Grade 3 | 70.15% (47) | 61.70% (87) | |
Antihypertensive agent | 0.109 | ||
No antihypertensive therapy | 73.13% (49) | 75.89% (107) | |
Angiotensin-converting enzyme inhibitors | 11.11% (2/18) | 11.76% (4/34) | |
Angiotensin receptor blockers | 33.33% (6/18) | 26.47% (9/34) | |
Beta-blockers | 0 | 5.88% (2/34) | |
Calcium channel blockers | 61.11% (11/18) | 58.82% (20/34) | |
Chinese traditional medicine | 11.11% (2/18) | 11.76% (4/34) | |
Combination therapy/ Monotherapy | 3/18 | 5/34 | 1.000 |
Previous blood pressure control | 0.566 | ||
< 120 mmHg | 0 | 0.71% (1) | |
120-140 mmHg | 5.97% (4) | 9.22% (13) | |
> 140 mmHg | 94.03% (63) | 90.07% (127) | |
Hypertensive cardiopathy | 52.24% (35) | 60.28% (85) | 0.295 |